Risk Factors

Hepatitis D Virus Predicts Liver Patient Morbidity and Mortality

Published in Hepatitis Weekly, April 24th, 2000

Researchers report in the journal Gut that patients with hepatitis D virus (HDV) are at increased risk for hepatocellular carcinoma (HCC) and may die faster when cirrhosis type B is present.

The researchers, led by G. Fattovich, conducted a retrospective cohort study of 200 patients in Europe who had compensated cirrhosis type B. These patients were followed for a median period of 6.6 years, according to the study report.

"Kaplan-Meier five-year probability of hepatocellular carcinoma (HCC) was 6, 10, and 9% in anti-HDV positive/HbeAg negative, anti-HDV negative/HbeAg negative, and anti-HDV negative /HbeAg positive cirrhotics, respectively,"...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2000-04-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry